Synopsis: Q-Centrix’s 2022 State of the Industry report discusses the expanding impact of clinical data in healthcare. In addition to sharing proprietary benchmarking data for select registries and outlining key registry and regulatory reporting updates from the past year, this report presents findings from a recent survey about how hospitals are using and sharing data for clinical research and health equity.
Details:
Clinical data are rapidly becoming the healthcare industry’s most valuable resource. Beyond their role in registry and regulatory reporting, clinical data hold immense value for use in driving medical research, advancing health equity, guiding operational efficiencies, and much more.
Our new 2022 State of the Industry report explores the expanding impact of clinical data in healthcare. In addition to sharing proprietary benchmarking data for select registries and outlining key registry and regulatory reporting updates from the past year, this report presents findings from our recent survey about how hospitals are currently using and sharing data for clinical research and health equity—and the barriers they face in these areas. These findings illustrate hospitals’ and health systems’ priorities, needs, and overall progress in their efforts to do more with their data.
This article is for:
Healthcare professionals, policymakers, researchers, investors, patients, and anyone interested in staying up-to-date on the latest trends, innovations, and challenges in the healthcare industry.
